Simultaneous initiation of finerenone and empagliflozin by baseline glucagon-like peptide-1 receptor agonist use: a prespecified analysis of CONFIDENCE

Ridhi Agarwal; J Green; Hiddo J.L. Heerspink; Johannes F E Mann; Janet B McGill; Amy K Mottl; Masaomi Nangaku; J. Rosenstock; Muthiah Vaduganathan; Meike Brinker; Charlie Scott; Li Li; Ni Li; Katja  Rohwedder; Peter Rossing

doi:10.1007/s00125-025-06497-1

Simultaneous initiation of finerenone and empagliflozin by baseline glucagon-like peptide-1 receptor agonist use: a prespecified analysis of CONFIDENCE

Ridhi Agarwal, J Green, Hiddo J.L. Heerspink, Johannes F E Mann, Janet B McGill, Amy K Mottl, Masaomi Nangaku, J. Rosenstock, Muthiah Vaduganathan, Meike Brinker, Charlie Scott, Li Li, Ni Li, Katja Rohwedder, Peter Rossing

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Artikelnummer	LBA 33
Tidsskrift	Diabetologia
Vol/bind	68
Udgave nummer	Suppl 1
Sider (fra-til)	S662
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-025-06497-1
Status	Udgivet - okt. 2025
Begivenhed	61th EASD Annual Meeting: EASD 2025 - Wien, Østrig Varighed: 15 sep. 2025 → 19 sep. 2025

Konference

Konference	61th EASD Annual Meeting: EASD 2025
Land/Område	Østrig
By	Wien
Periode	15/09/2025 → 19/09/2025

Adgang til dokumentet

10.1007/s00125-025-06497-1Licens: Ikke-specificeret

Citationsformater

Agarwal, R., Green, J., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Mottl, A. K., Nangaku, M., Rosenstock, J., Vaduganathan, M., Brinker, M., Scott, C., Li, L., Li, N., Rohwedder, K., & Rossing, P. (2025). Simultaneous initiation of finerenone and empagliflozin by baseline glucagon-like peptide-1 receptor agonist use: a prespecified analysis of CONFIDENCE. Diabetologia, 68(Suppl 1), S662. Artikel LBA 33. https://doi.org/10.1007/s00125-025-06497-1

Simultaneous initiation of finerenone and empagliflozin by baseline glucagon-like peptide-1 receptor agonist use: a prespecified analysis of CONFIDENCE. / Agarwal, Ridhi; Green, J; Heerspink, Hiddo J.L. et al.
I: Diabetologia, Bind 68, Nr. Suppl 1, LBA 33, 10.2025, s. S662.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Agarwal, R, Green, J, Heerspink, HJL, Mann, JFE, McGill, JB, Mottl, AK, Nangaku, M, Rosenstock, J, Vaduganathan, M, Brinker, M, Scott, C, Li, L, Li, N, Rohwedder, K & Rossing, P 2025, 'Simultaneous initiation of finerenone and empagliflozin by baseline glucagon-like peptide-1 receptor agonist use: a prespecified analysis of CONFIDENCE', Diabetologia, bind 68, nr. Suppl 1, LBA 33, s. S662. https://doi.org/10.1007/s00125-025-06497-1

@article{70b786fe42074437be7f201d241fff30,

title = "Simultaneous initiation of finerenone and empagliflozin by baseline glucagon-like peptide-1 receptor agonist use: a prespecified analysis of CONFIDENCE",

author = "Ridhi Agarwal and J Green and Heerspink, {Hiddo J.L.} and Mann, {Johannes F E} and McGill, {Janet B} and Mottl, {Amy K} and Masaomi Nangaku and J. Rosenstock and Muthiah Vaduganathan and Meike Brinker and Charlie Scott and Li Li and Ni Li and Katja Rohwedder and Peter Rossing",

year = "2025",

month = oct,

doi = "10.1007/s00125-025-06497-1",

language = "English",

volume = "68",

pages = "S662",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "Suppl 1",

note = "61th EASD Annual Meeting: EASD 2025, EASD ; Conference date: 15-09-2025 Through 19-09-2025",

}

TY - ABST

T1 - Simultaneous initiation of finerenone and empagliflozin by baseline glucagon-like peptide-1 receptor agonist use: a prespecified analysis of CONFIDENCE

AU - Agarwal, Ridhi

AU - Green, J

AU - Heerspink, Hiddo J.L.

AU - Mann, Johannes F E

AU - McGill, Janet B

AU - Mottl, Amy K

AU - Nangaku, Masaomi

AU - Rosenstock, J.

AU - Vaduganathan, Muthiah

AU - Brinker, Meike

AU - Scott, Charlie

AU - Li, Li

AU - Li, Ni

AU - Rohwedder, Katja

AU - Rossing, Peter

PY - 2025/10

Y1 - 2025/10

U2 - 10.1007/s00125-025-06497-1

DO - 10.1007/s00125-025-06497-1

M3 - Conference abstract in journal

SN - 0012-186X

VL - 68

SP - S662

JO - Diabetologia

JF - Diabetologia

IS - Suppl 1

M1 - LBA 33

T2 - 61th EASD Annual Meeting: EASD 2025

Y2 - 15 September 2025 through 19 September 2025

ER -